NO176232C - Fremgangsmåte for fremstilling av en fast, oral doseringsform med regulert frigivelse av medikament - Google Patents

Fremgangsmåte for fremstilling av en fast, oral doseringsform med regulert frigivelse av medikament

Info

Publication number
NO176232C
NO176232C NO892229A NO892229A NO176232C NO 176232 C NO176232 C NO 176232C NO 892229 A NO892229 A NO 892229A NO 892229 A NO892229 A NO 892229A NO 176232 C NO176232 C NO 176232C
Authority
NO
Norway
Prior art keywords
dosage form
controlled release
oral dosage
drug
preparation
Prior art date
Application number
NO892229A
Other languages
English (en)
Norwegian (no)
Other versions
NO176232B (no
NO892229D0 (no
NO892229L (no
Inventor
Joanne Heafield
Stewart Thomas Leslie
Sandra Therese Antoi Malkowska
Philip John Neale
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of NO892229D0 publication Critical patent/NO892229D0/no
Publication of NO892229L publication Critical patent/NO892229L/no
Publication of NO176232B publication Critical patent/NO176232B/no
Publication of NO176232C publication Critical patent/NO176232C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO892229A 1988-06-02 1989-06-01 Fremgangsmåte for fremstilling av en fast, oral doseringsform med regulert frigivelse av medikament NO176232C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888813064A GB8813064D0 (en) 1988-06-02 1988-06-02 Controlled release dosage forms having defined water content

Publications (4)

Publication Number Publication Date
NO892229D0 NO892229D0 (no) 1989-06-01
NO892229L NO892229L (no) 1989-12-04
NO176232B NO176232B (no) 1994-11-21
NO176232C true NO176232C (no) 1995-03-01

Family

ID=10637952

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892229A NO176232C (no) 1988-06-02 1989-06-01 Fremgangsmåte for fremstilling av en fast, oral doseringsform med regulert frigivelse av medikament

Country Status (19)

Country Link
US (1) US5091189A (ja)
EP (1) EP0344960B1 (ja)
JP (1) JPH0816060B2 (ja)
KR (1) KR0136279B1 (ja)
AT (1) ATE83925T1 (ja)
AU (1) AU610401B2 (ja)
CA (1) CA1323834C (ja)
DE (1) DE68904119T2 (ja)
DK (1) DK175130B1 (ja)
ES (1) ES2053989T3 (ja)
FI (1) FI93695C (ja)
GB (2) GB8813064D0 (ja)
GR (1) GR3007088T3 (ja)
IE (1) IE61998B1 (ja)
IL (1) IL90462A (ja)
NO (1) NO176232C (ja)
NZ (1) NZ229372A (ja)
PT (1) PT90722B (ja)
ZA (1) ZA894201B (ja)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
TR200001942T2 (tr) 1997-12-22 2000-11-21 Euro-Celtique, S.A. Opioid agonist/antagonist kombinasyonlar
CN1204890C (zh) * 1997-12-22 2005-06-08 欧罗赛铁克股份有限公司 防止阿片样物质滥用的方法
WO2000030446A1 (en) 1998-11-23 2000-06-02 Bonnie Davis Dosage formulations for acetylcholinesterase inhibitors
SI2283842T1 (sl) * 2000-02-08 2015-07-31 Euro-Celtique S.A. Oralne formulacije opioidnih agonistov, varne pred zlorabo
EP1387673B1 (en) 2001-05-11 2010-12-29 Endo Pharmaceuticals Inc. Abuse-resistant controlled-release opioid dosage form
US7052706B2 (en) * 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
DK1416842T3 (da) * 2001-07-18 2009-03-16 Euro Celtique Sa Farmaceutiske kombinationer af oxycodon og naloxon
US20030157168A1 (en) * 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
ES2326794T3 (es) 2001-08-06 2009-10-20 Euro-Celtique S.A. Formulaciones de agonistas opioides con antagonista liberable y secuestrado.
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
IN192180B (ja) * 2001-09-28 2004-03-06 Ranbaxy Lab
PT1485078E (pt) * 2002-03-15 2013-01-14 Cypress Bioscience Inc Milnacipran para o tratamento do síndrome do intestino irritável
LT2425821T (lt) 2002-04-05 2017-07-25 Euro-Celtique S.A. Farmacinis preparatas, turintis oksikodono ir naloksono
SI1551372T1 (en) 2002-09-20 2018-08-31 Alpharma Pharmaceuticals Llc SUBVENCATION DATA AND RELATED CONSTRUCTIONS AND PROCEDURES
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
AU2004207578B2 (en) * 2003-01-28 2007-06-28 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US20040202717A1 (en) * 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP2039349A1 (en) * 2004-10-19 2009-03-25 KRKA, tovarna zdravil, d.d., Novo mesto Solid pharmaceutical composition comprising donepezil hydrochloride
EP1702558A1 (en) * 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
ZA200802602B (en) * 2005-08-24 2009-10-28 Rubicon Res Pvt Ltd Controlled release formulation
SI2484346T1 (sl) 2006-06-19 2017-05-31 Alpharma Pharmaceuticals Llc Farmacevtski sestavki
BRPI0717149B1 (pt) * 2006-09-29 2016-02-16 Procter & Gamble composição oral contendo redes de gel e processo para o preparo da mesma.
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US20100266645A1 (en) * 2007-12-17 2010-10-21 Alfred Liang Pharmaceutical compositions
SI2317991T1 (sl) * 2008-07-07 2017-09-29 Euro-Celtique S.A. Uporaba opioidnih antagonistov za zdravljenje retencije urina
PL2405915T3 (pl) 2009-03-10 2019-05-31 Euro Celtique Sa Kompozycje farmaceutyczne o natychmiastowym uwalnianiu zawierające oksykodon i nalokson
KR20160034352A (ko) 2013-07-23 2016-03-29 유로-셀티큐 에스.에이. 장내 세균총이상을 초래하고/하거나 장내 박테리아 전위에 대한 위험을 증가시키는 질환과 통증으로 인해 고통받고 있는 환자에서 통증을 치료하는데 사용하기 위한 옥시코돈과 날록손의 조합물
CN114053235B (zh) * 2020-08-07 2023-07-18 广州白云山光华制药股份有限公司 茶碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
FR2535202B1 (fr) * 1982-11-03 1985-08-09 Fabre Sa Pierre Comprimes de theophylline a liberation controlee et leur procede de fabrication
US4743247A (en) * 1984-08-13 1988-05-10 Alza Corporation Process for manufacturing dosage form
US4753800A (en) * 1985-10-04 1988-06-28 Warner-Lambert Company Medicament adsorbates and their preparation
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
ES2058111T3 (es) * 1986-06-10 1994-11-01 Euro Celtique Sa Composicion de liberacion controlada de dihidrocodeina.
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids

Also Published As

Publication number Publication date
KR900000077A (ko) 1990-01-30
IE61998B1 (en) 1994-12-14
NO176232B (no) 1994-11-21
DK266889A (da) 1989-12-03
GB8911629D0 (en) 1989-07-05
EP0344960A3 (en) 1990-03-07
FI93695C (fi) 1995-05-26
IE891744L (en) 1989-12-02
IL90462A0 (en) 1990-01-18
DE68904119D1 (de) 1993-02-11
EP0344960A2 (en) 1989-12-06
AU610401B2 (en) 1991-05-16
ES2053989T3 (es) 1994-08-01
KR0136279B1 (ko) 1998-04-25
ZA894201B (en) 1990-03-28
NZ229372A (en) 1991-07-26
IL90462A (en) 1993-01-31
FI892664A0 (fi) 1989-06-01
ATE83925T1 (de) 1993-01-15
PT90722B (pt) 1994-11-30
DE68904119T2 (de) 1993-06-09
GB2219207B (en) 1992-01-02
GB2219207A (en) 1989-12-06
FI892664L (fi) 1989-12-03
NO892229D0 (no) 1989-06-01
NO892229L (no) 1989-12-04
DK266889D0 (da) 1989-06-01
US5091189A (en) 1992-02-25
CA1323834C (en) 1993-11-02
GB8813064D0 (en) 1988-07-06
FI93695B (fi) 1995-02-15
DK175130B1 (da) 2004-06-14
JPH0816060B2 (ja) 1996-02-21
AU3512789A (en) 1989-12-07
JPH0225420A (ja) 1990-01-26
PT90722A (pt) 1989-12-29
GR3007088T3 (ja) 1993-07-30
EP0344960B1 (en) 1992-12-30

Similar Documents

Publication Publication Date Title
NO892229D0 (no) Fremgangsmaate for fremstilling av en fast, oral doseringsform med regulert frigivelse av medikament.
DK568687A (da) Hydromorphonpraeparat med reguleret afgivelse
IE820165L (en) Continuous release pharmaceutical compositions
IL83363A (en) Use of indol-3-yl-carboxylic acid endo-8-methyl-8-aza- bicyclo (3,2,1) oct-3-yl ester for the preparation of psycho-active pharmaceutical compositions suitable for the treatment of stress- related psychiatric disorders or for increasing vigilance
SE8505099L (sv) Pulver med reglerad frigoring samt sett for framstellning derav
EP0449247A3 (en) Pharmaceutical composition containing galanthamine for treating alcoholism
IL87922A (en) Pharmaceutical compositions containing dihydropyridine derivatives in combination with metoprolol and process for their preparation
EP0068450A3 (en) Pharmaceutical forms for oral administration
PT79786A (fr) Procede de preparation d'1ne matrice inerte a base de polycaprolactone pour administration orale d'un medicament
AU1196988A (en) Process for preparing a retard product containing diltiazem for a single daily administration
GR3007347T3 (ja)
ES500670A0 (es) Procedimiento de preparar farmacos con liberacion programada de materia activa.
FR2518881B1 (fr) Medicaments a base de 26,23-lactones de la 25-hydroxyvitamine d3, utiles notamment pour agir sur la concentration en calcium du serum
EP0269452A3 (en) Use of ketone derivatives for the manufacture of medicaments
HUT53610A (en) Herbicides containing derivatives of 5-(3,4,5,6-tetrahydroftalamid)-cinnamon acid and process for production of the active substances
IT8882523A0 (it) Metodo per l'avanzamento del piede particolarmente nei pedali per velocipedi.
JPS5626819A (en) Preventive for hypoimmunity
JPS56127307A (en) Blood-coagulation factor 8 pharmaceutical for oral administration
EP0135657A3 (en) Antibacterial drugs and/or feed concentrates
ATE95174T1 (de) 1,4-dihydropyridin-derivate, verfahren zu ihrer herstellung, pharmazeutische zusammensetzung und ihre verwendung.

Legal Events

Date Code Title Description
MK1K Patent expired